Legaspi, Marilyn .
HRN: 23-97-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 1.5GM (VIAL)
11/17/2023
11/19/2023
IV
1.5 G
Q8
Sp LTCS
Checking Final Appropriateness
11/18/2023
CEFUROXIME 500MG (TAB)
11/18/2023
11/25/2023
PO
500 Mg
BID
S/P LSCS
Checking Final Appropriateness